Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine

Published:2021-08 Issue:8 Volume:47 Page:2209-2210
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Kapacee Zainul Abedin^ORCID,McNamara Mairéad G.,de Liguori Carino Nicola,Lamarca Angela^ORCID,Valle Juan W.,Hubner Richard A.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference7 articles.

1. Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare?;Kapacee;Eur J Surg Oncol,2020

2. Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept;De Lorenzo;Sci Rep,2018

3. Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases;Marinelli;Hepat Mon,2013

4. Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure;Granito;Dig Liver Dis,2015

5. Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation;Trevisani;J Canc Res Clin Oncol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP